Completed PHASE4 INTERVENTIONAL 2-arm NCT00850889

Juvederm Ultra With Lidocaine Compared With Restylane for the Correction of Nasolabial Folds

Sponsor: Allergan Medical

Interventions A gel of hyaluronic acid (concentration of 20 mg/mL) Hyaluronic acid gel (24 mg/mL) with 0.3% lidocaine

Updated 9 times since 2017 Last updated: Dec 19, 2018 Started: Nov 30, 2008 Primary completion: Nov 30, 2008 Completion: Nov 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00850889, this PHASE4 trial focuses on Nasolabial Folds and remains completed. Sponsored by Allergan Medical, it has been updated 9 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4
Jan 2021 — Dec 2022 [monthly]

Completed PHASE4

▶ Show 4 earlier versions

Feb 2019 — Jan 2021 [monthly]

Completed PHASE4
Jun 2018 — Feb 2019 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Nov 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Allergan Medical

Data source: Allergan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Niagara Falls, Canada